Amneal Pharmaceuticals Inc (AMRX) USD0.01 A

Sell:$6.50Buy:$8.55$0.06 (0.81%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$6.50
Buy:$8.55
Change:$0.06 (0.81%)
Market closed | Prices delayed by at least 15 minutes
Sell:$6.50
Buy:$8.55
Change:$0.06 (0.81%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 April 2025
Gautam PatelIndependent Director
Sell
Regular sell transaction (market)
80,000$8.30$664,000.001,728,886
14 March 2025
Tushar Bhikhubhai Patel10% Owner
Sell
Regular sell transaction (market)
5,000,000$8.35$41,750,000.0048,578,209
6 March 2025
Jason B DalyChief Legal/Compliance Officer
Sell
Option/Award related
46,936$8.73$409,751.2832,606
5 March 2025
Anastasios G. (Tasos) KonidarisCFO
Sell
Option/Award related
100,000$8.91$891,000.00621,882
5 March 2025
Andrew S (Andy) BoyerExecutive Vice President
Sell
Option/Award related
125,000$8.89$1,111,250.00290,106
5 March 2025
Emily Peterson AlvaDirector
Sell
Option/Award related
80,000$8.90$712,000.00170,771
5 March 2025
Jason B DalyChief Legal/Compliance Officer
Sell
Option/Award related
43,064$8.88$382,408.3279,542
4 March 2025
Chintu PatelCEO
Sell
Tax related
46,528$8.84$411,307.52864,033
4 March 2025
Chirag K PatelPresident/CEO
Sell
Tax related
47,361$8.84$418,671.24857,980
4 March 2025
Anastasios G. (Tasos) KonidarisCFO
Sell
Tax related
22,497$8.84$198,873.48721,882

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 March 2025
Tushar Bhikhubhai Patel10% Owner
Sell
Regular sell transaction (market)
5,000,000$8.35$41,750,000.0048,578,209
3 March 2025
Chirag K PatelPresident/CEO
Sell
Tax related
279,527$8.76$2,448,656.52812,749
3 March 2025
Chintu PatelCEO
Sell
Tax related
274,307$8.76$2,402,929.32817,969
5 March 2025
Andrew S (Andy) BoyerExecutive Vice President
Sell
Option/Award related
125,000$8.89$1,111,250.00290,106
5 March 2025
Anastasios G. (Tasos) KonidarisCFO
Sell
Option/Award related
100,000$8.91$891,000.00621,882

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.